William A. Murphy

Radiology
13900 Katy Fwy
Houston, TX 77079

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Rare case of ulnar cryptococcal osteomyelitis in a 26-year-old immunocompetent patient.

Rare case of ulnar cryptococcal osteomyelitis in a 26-year-old immunocompetent patient.

Journal: Radiology case reports
Published: December 29, 2025

A follow-up study on the novel use of contrast-enhanced susceptibility-weighted imaging for extremity desmoid fibromatosis response assessment.

A follow-up study on the novel use of contrast-enhanced susceptibility-weighted imaging for extremity desmoid fibromatosis response assessment.

Journal: Scientific reports
Published: January 28, 2025

Novel Use and Value of Contrast-Enhanced Susceptibility-Weighted Imaging Morphologic and Radiomic Features in Predicting Extremity Soft Tissue Undifferentiated Pleomorphic Sarcoma Treatment Response.

Novel Use and Value of Contrast-Enhanced Susceptibility-Weighted Imaging Morphologic and Radiomic Features in Predicting Extremity Soft Tissue Undifferentiated Pleomorphic Sarcoma Treatment Response.

Journal: JCO clinical cancer informatics
Published: January 22, 2025

Building a pre-surgical multiparametric-MRI-based morphologic, qualitative, semiquantitative, first and high-order radiomic predictive treatment response model for undifferentiated pleomorphic sarcoma to replace RECIST.

Building a pre-surgical multiparametric-MRI-based morphologic, qualitative, semiquantitative, first and high-order radiomic predictive treatment response model for undifferentiated pleomorphic sarcoma to replace RECIST.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: November 30, 2024

Perfusion-weighted imaging with dynamic contrast enhancement (PWI/DCE) morphologic, qualitative, semiquantitative, and radiomics features predicting undifferentiated pleomorphic sarcoma (UPS) treatment response.

Perfusion-weighted imaging with dynamic contrast enhancement (PWI/DCE) morphologic, qualitative, semiquantitative, and radiomics features predicting undifferentiated pleomorphic sarcoma (UPS) treatment response.

Journal: Scientific reports
Published: June 15, 2024

Cancer Radiomic and Perfusion Imaging Automated Framework: Validation on Musculoskeletal Tumors.

Cancer Radiomic and Perfusion Imaging Automated Framework: Validation on Musculoskeletal Tumors.

Journal: JCO clinical cancer informatics
Published: January 05, 2024

Role of Apparent Diffusion Coefficient Map-Based First- and High-Order Radiomic Features for the Discrimination of Sacral Chordomas and Chondrosarcomas With Overlapping Conventional Imaging Features.

Role of Apparent Diffusion Coefficient Map-Based First- and High-Order Radiomic Features for the Discrimination of Sacral Chordomas and Chondrosarcomas With Overlapping Conventional Imaging Features.

Journal: JCO precision oncology
Published: December 21, 2023

Bone Metastases: Mechanisms of the Metastatic Process, Imaging and Therapy.

Bone Metastases: Mechanisms of the Metastatic Process, Imaging and Therapy.

Journal: Seminars in ultrasound, CT, and MR
Published: April 05, 2021

Osteonecrosis of the jaw induced by treatment with anti-PD-1 immunotherapy: a case report.

Osteonecrosis of the jaw induced by treatment with anti-PD-1 immunotherapy: a case report.

Journal: Immunotherapy
Published: September 09, 2020

RS3PE Following Treatment With Combination of Hormonal Therapies Plus Ipilimumab in a Patient With Metastatic Prostate Cancer.

RS3PE Following Treatment With Combination of Hormonal Therapies Plus Ipilimumab in a Patient With Metastatic Prostate Cancer.

Journal: Journal of immunotherapy and precision oncology
Published: February 04, 2020

Gadolinium-based Contrast Agents Improve Detection of Recurrent Soft-Tissue Sarcoma at MRI.

Gadolinium-based Contrast Agents Improve Detection of Recurrent Soft-Tissue Sarcoma at MRI.

Journal: Radiology. Imaging cancer
Published: June 27, 2019

Tumor-induced hypophosphatemic osteomalacia caused by a mesenchymal tumor of the mandible managed by a segmental mandibulectomy and microvascular reconstruction with a free fibula flap.

Tumor-induced hypophosphatemic osteomalacia caused by a mesenchymal tumor of the mandible managed by a segmental mandibulectomy and microvascular reconstruction with a free fibula flap.

Journal: Head & neck
Published: July 12, 2018
Showing 1-12 of 22

Last Updated: 09/26/2026